%0 Journal Article
%A Ferra-Murcia, Sergio
%A Collado-Romacho, Antonio Ramón
%A Nievas-Soriano, Bruno José
%A Reche-Lorite, Fernando
%A Parrón-Carreño, Tesifón
%T Real-Life Early Anthropometric, Lipid and Liver Changes after Direct-Acting Antiviral Therapy in PLWHIV with HCV Co-Infection.
%D 2022
%@ 2077-0383
%U http://hdl.handle.net/10668/21283
%X Treatment with interferon-free direct-acting antivirals (DAA) has become the gold standard in chronic hepatitis C virus (HCV) infection. Nevertheless, little research about the metabolic impact of achieving sustained virological response (SVR) is available in HCV/HIV co-infected patients. This research aimed to evaluate early anthropometric, lipid and liver parameters changes after achieving SVR 12 weeks after treatment (SVR12). A real-life retrospective descriptive before-after study assessed 128 DAA treatment episodes from 2015 to 2019 in HCV/HIV co-infected patients. Anthropometric parameters (weight, body mass index), lipid profile, genotype (GT) and viral load, liver data (basics laboratory necroinflammatory parameters and transient elastography (TE)) were collected before treatment with DAA (baseline), and when SVR12 was achieved. Significant increases (p
%K HCV/HIV co-infected
%K before-after DAA therapy
%K comorbidity PLWHIV
%K direct-acting antivirals
%K metabolic impact
%~